+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1480833-70-2
1480833-70-2,MFCD26792589
Catalog No.:AA01LRBT

1480833-70-2 | 2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%(HPLC)
in stock  
$268.00   $188.00
- +
10mg
≥98%(HPLC)
in stock  
$393.00   $275.00
- +
25mg
≥98%(HPLC)
in stock  
$815.00   $570.00
- +
50mg
≥98%(HPLC)
in stock  
$1,241.00   $869.00
- +
100mg
≥98%(HPLC)
in stock  
$2,143.00   $1,500.00
- +
250mg
≥98%(HPLC)
in stock  
$4,752.00   $3,327.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01LRBT
Chemical Name:
2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine
CAS Number:
1480833-70-2
Molecular Formula:
C13H14F3N3O
Molecular Weight:
285.2650
MDL Number:
MFCD26792589
SMILES:
FC(Oc1ccc(cc1)c1cnc([nH]1)C(N)(C)C)(F)F
Properties

Downstream Synthesis Route
1480833-70-2   
CASUnavailable 
  2162950-56-1 

[1]Bagal,SharanK.;Kemp,MarkI.;Bungay,PeterJ.;Hay,TanyaL.;Murata,Yoshihisa;Payne,C.Elizabeth;Stevens,EdwardB.;Brown,Alan;Blakemore,DavidC.;Corbett,MatthewS.;Miller,DuncanC.;Omoto,Kiyoyuki;Warmus,JosephS.[MedChemComm,2016,vol.7,#10,p.1925-1931]

1480833-70-2   
CASUnavailable 
  2162957-48-2 

[1]Bagal,SharanK.;Kemp,MarkI.;Bungay,PeterJ.;Hay,TanyaL.;Murata,Yoshihisa;Payne,C.Elizabeth;Stevens,EdwardB.;Brown,Alan;Blakemore,DavidC.;Corbett,MatthewS.;Miller,DuncanC.;Omoto,Kiyoyuki;Warmus,JosephS.[MedChemComm,2016,vol.7,#10,p.1925-1931]

CASUnavailable 
  1480833-70-2 

[1]Bagal,SharanK.;Kemp,MarkI.;Bungay,PeterJ.;Hay,TanyaL.;Murata,Yoshihisa;Payne,C.Elizabeth;Stevens,EdwardB.;Brown,Alan;Blakemore,DavidC.;Corbett,MatthewS.;Miller,DuncanC.;Omoto,Kiyoyuki;Warmus,JosephS.[MedChemComm,2016,vol.7,#10,p.1925-1931]

Literature

Title: Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1480833-70-2
1351661-47-6

1351661-47-6
Building Blocks
More >
Tags:1480833-70-2 Molecular Formula|1480833-70-2 MDL|1480833-70-2 SMILES|1480833-70-2 2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amine